Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
07/2003
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2469042A1 Triazoles as oxytocin antagonists
07/02/2003EP1322625A2 Reagents for labeling biomolecules having aldehyde or ketone moieties
07/02/2003EP0913392B1 Ethylene derivatives and pest controlling agents
07/02/2003EP0882027B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones as herbicides
07/01/2003US6586594 Reacting 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl) ethanone and 6-(1-bromoethyl)-4-chloro-5-fluoropyrimidine in the presence of zinc, iodine, lewis acids, aprotic solvents and optionally lead to form sterospecific fungicides
07/01/2003US6586466 Carbohydrazide-protease inhibitors
07/01/2003US6586437 (S)-hydroxynefazodone antipsychotic therapy
06/2003
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2001066551A8 Azole compounds as therapeutic agents for fungal infections
06/26/2003US20030120083 Diazotizing perfluoroalkyl-o-nitroaniline with sulfuric acid and sodium nitrite, coupling with phenol to form monoazo-benzene, reducing to form compound such as 5-trifluoromethyl-2-(2-hydroxy-3-a-cumyl-5-tert-octylphenyl)-2H -benzotriazole
06/26/2003US20030119670 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003EP0871650B1 Solid phase organic synthesis
06/24/2003US6583293 Nitrating 1,2,4-triazol-5-one in mix of sulfuric acid and nitric acid under controlled temperature gradient conditions
06/24/2003US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583090 Hetaryl-substituted benzyl phenyl ethers, method for the production thereof, and their use for combating harmful fungi and animal pests
06/24/2003US6582952 Conversion of nitro group to preferential amine; obtain chemical intermediates, mix in nutrient broths, inoculate with bacillus, propagate, separate bacillus from solution, recover amine
06/24/2003CA2272014C N-aryl/heteroaryl-substituted heterocycles
06/19/2003WO2003051092A1 [5] helicene AND dibenzofluorene MATERIALS FOR USE IN ORGANIC LIGHT EMITTING DEVICES
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050093A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003CA2469147A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1202627B1 Fungicidal combinations of active substances
06/18/2003EP0757677B1 Benzocyclohexylimidazolethione derivatives
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579633 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines
06/12/2003WO2003048257A1 Organic solvent-free process for the preparation of 2-(2-nitrophenylazo)phenols
06/12/2003WO2003048134A1 Triazole compound and medicinal use thereof
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003CA2465398A1 Organic solvent-free process for the preparation of 2-(2-nitrophenylazo)phenols
06/11/2003EP1060161B1 Matrix metalloproteinase inhibitors
06/11/2003EP0956283B1 Substituted phenyltriazolin(thi)ones and their use as herbicides
06/11/2003EP0779894B1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
06/11/2003CN1422850A Fluoro-contained 1H-1,2,3-triazaazole compounds, preparation method thereof and their use
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045925A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003035043A3 Pharmaceutical formulation comprising more than 15% tamoxifen
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105105 As anticoagulant agents for therapy and prophylaxis of thromboembolic disorders
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030101901 Surface treated cartbon black
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/04/2003EP1115711B1 Regioselective fluorination of phenyl-substituted triazolinones
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003EP0967210B1 Process for preparing biologically active derivatives of 1,2,4-triazol and intermediaries useful in this process
06/04/2003EP0809637B1 Fungicidal aza-heterocycloalkenes
06/04/2003CN1422257A Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
06/03/2003US6573379 Method for preparing halomethyl heterocyclic compounds
05/2003
05/29/2003US20030098440 Adhesion promoters containing benzotriazoles
05/28/2003EP0882705B1 Bis(aminocarbonylnaphthol) derivative
05/28/2003CN1420874A Process for preparing aryltriazolinones and novel intermediates thereto
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6569902 Inhibiting initiation or development of cancer by administering an effective dose of a nitrone free radical trapping agent to a subject
05/22/2003WO2003042211A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042189A1 Process for producing 1-h-1,2,4-triazole-3-carboxylic acid ester
05/22/2003WO2003042188A1 Triazole derivative and medicinal composition containing the same
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003CA2467267A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1109107C Chiral synthesis of tertiary alcohols with a hydrolase
05/20/2003US6566507 Processes for the preparation of benzotriazole UV absorbers
05/20/2003US6566383 Sulfonyltriazol derivatives and their use for combating micro-organisms
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040112A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003WO2003040110A1 Triazole derivatives as cyclooxygenase (cox) inhibitors
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039541A1 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092685 Administering a (bi- or tri)phenol compound containing a nitrogen ring
05/15/2003US20030092680 Novel pesticides
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465189A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/14/2003EP1310491A1 Method for producing 1-substituted-1,2,3-triazole derivative
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1109790B1 1, 2, 4-triazole-3-thione compounds
05/13/2003US6562972 Method for preparing quinoxaline-5- and 6-carboxylic acids (I) which comprises contacting an aqueous alkaline suspension of a 5- or 6-halomethyl quinoxaline (II) with oxygen in the presence of a transition metal catalyst, to form the
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037880A1 Low dusting crystal transformations of 2, 2'-methylenbis[4-(1,1,3,3-tetramethylbutyl)-6-benzotriazolylphenol] and mixture thereof, method for preparing them, and ultraviolet absorbent using the same
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 178